← Back to Clinical Trials
Recruiting NCT07591272

NCT07591272 Adaptive Dance Activities for People With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07591272
Status Recruiting
Phase
Sponsor Chinese University of Hong Kong
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2025-01-01
Primary Completion 2028-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Movement Improvisation Skill-building and Adaptive Dance Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2025-01-01 with a primary completion date of 2028-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The project will investigate the effects of a novel 12-week Movement Improvisation Skill-building and Adaptive Dance Intervention (MDI) on participation, balance, mobility, balance confidence, psychological well-being, and health-related quality of life in survivors with hemiparesis.

Eligibility Criteria

Inclusion Criteria: * a first-ever/recurrent ischaemic/haemorrhagic stroke confirmed by imaging tests, * receiving in-patient care at an acute stroke unit, * a National Institutes of Health Stroke Scale (NIHSS) total score of \<16 (mild to moderate stroke), * hemiparesis after stroke with the affected limb(s) scoring 1-3 on the NIHSS motor arm and/or motor leg items, respectively (drift to no effort against gravity), * a modified Rankin Scale (mRS) score of 2-4 (slight to moderately severe disability), and * a Montreal Cognitive Assessment (MoCA) score of \>2nd percentile. Exclusion Criteria: * transient ischaemic attack, * subdural or epidural haemorrhage, * cerebrovascular event due to brain tumour or a head injury, * neurologic, orthopaedic, muscular, rheumatic or vestibular condition that can interfere with participation in the intervention such as seizure or spinal injury, * mental condition such as depression or schizophrenia, or * visual or auditory impairment that cannot be corrected by visual/hearing aids.

Contact & Investigator

Central Contact

Suzanne HS Lo, PhD

✉ suzannelo@cuhk.edu.hk

📞 852-39434485

Frequently Asked Questions

Who can join the NCT07591272 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07591272 currently recruiting?

Yes, NCT07591272 is actively recruiting participants. Contact the research team at suzannelo@cuhk.edu.hk for enrollment information.

Where is the NCT07591272 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07591272 clinical trial?

NCT07591272 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 160 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology